Unitaid at IAS 2017

Unitaid will be at this year's International AIDS Society conference (IAS 2017) at the Palais des Congrès in Paris, 23-26 July.

For the full schedule of Unitaid events, click here.

Daily summaries:

Check out our Storify summary of day one!

Summary of day two

Summary of day three

Summary of day four

We’re tweeting from the conference. Follow Unitaid, hashtag #ias2017

Don’t miss this Satellite symposium, jointly organised by Unitaid and ANRS:

A more effective response to HIV / AIDS: The Role of Value for Money

23 July – 2.45pm to 4.45pm – Room 251

The panel will discuss how to improve Value for Money of the HIV / AIDS response, with a particular focus on resource-limited settings. They will examine how donors, countries, communities and experts from the fields of public health and economics can work together to optimize the impact of the resources available for testing, preventing, treating and monitoring HIV / AIDS.


There is a strong global consensus that we now have the tools to end the AIDS epidemic as a global health threat. HIV treatment can dramatically extend the lifespan of people living with HIV. Effective prevention tools, including PrEP, are now available, alongside innovative diagnostic and testing approaches such as quality self-testing products. Combined with broader social and structural approaches to eliminate stigma and discrimination, there is a unique opportunity to end one of the most devastating modern day health challenges.

To accelerate progress towards ending the epidemic, the international community adopted the “Fast Track” targets, which aim to secure 90 per cent of people living with HIV knowing their HIV status, 90 per cent of people who know their status receiving treatment and 90 per cent of people on HIV treatment having a suppressed viral load by 2020. To achieve this, in a context of international funding constraints, there is a need to get the most out of every dollar invested in the HIV response.

This symposium will discuss how to improve the Value for Money of the HIV/AIDS response, with particular focus on resource-limited settings. It will examine how donors, countries, communities, and experts from the public health and economics fields can work together to optimize the impact of available resources in testing, preventing, treating and monitoring HIV/AIDS.

This symposium is jointly organized by ANRS and Unitaid in the context of the 9th Conference on HIV Science in Paris (IAS 2017). It will take place from 2.45pm to 4.45pm on 23 July 2017 at the Palais des Congrès, 2 Place de la Porte Maillot, 75017 Paris. The symposium will comprise of one key note speech, and two panels with four panelists each, covering the topics i) HIV treatment and ii) HIV diagnosis and monitoring. The symposium will be delivered in English.

Draft agenda

Opening of the symposium by Philippe Duneton, deputy executive director of Unitaid and François Dabis, executive director of ANRS.

Keynote speech
Jean-Paul Moatti
CEO of the Institut de Recherche pour le Développement (IRD).

Panel 1: Value for Money in HIV treatment


Yazdan Yazdanpanah 

Professor of Infectious Disease, Bichat Claude Bernard Hospital and Paris Diderot University, France.


Eric Delaporte 

An epidemiologist, Professor of infectious diseases, and head of unit for operational research on HIV and infectious diseases at the University of Montpellier.

Sinata Koulla Shiro MD

Secretary General of the Cameroon Ministry of Health (MOH), Professor of Microbiology and Infectious Diseases at the Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I (UY1) in Cameroon.

Kalipso Chalkidou

Director of the Global Health and Development Group at the Institute of Global Health Innovation, Imperial College London.

Yogan Pillay

Deputy Director-General at the South African National Department of Health and is responsible for the following health programmes: HIV & AIDS, TB and Maternal, Child and Women’s Health (MCWH).

Questions and Answers session.

Panel 2: Value for Money in HIV testing and monitoring


Charlotte Watts

Chief Scientific Adviser at DFID.


Christine Rouzioux 

Professor of Virology at Necker Hospital and University Paris Descartes.

Kenly Sikwese

Coordinator at the African community Advisory Board (AFROCAB). Communities Alternate Board Member for Unitaid, Co-Chair of the UNAIDS Treatment Scientific and Technical Advisory Committee, Member of the INTEREST Virology  Workshop/Conference and IAPAC Adherence Organizing and Scientific Committees.

Ade Fakoya

Senior Disease Coordinator, HIV/AIDS, The Global Fund.


Vincent Bretin

Results team leader, Unitaid.

Questions and Answers session.

Closing remarks

Michèle Boccoz

French Ambassador for the fight against HIV/AIDS and communicable diseases.

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.